Vishrutha Poojari
Overview
Explore the profile of Vishrutha Poojari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agibothu Kupparam H, Shah I, Chandrasekaran P, Mane S, Sharma S, Thangavelu B, et al.
J Antimicrob Chemother
. 2024 Sep;
79(11):2939-2947.
PMID: 39308327
Background: Drug-resistant tuberculosis (DR-TB) is one of the challenging forms of TB to treat, not only in adults but also in children and adolescents. Further, there is a void in...
2.
Poojari V, Shah K, Shah I
Pediatr Infect Dis J
. 2023 Nov;
42(12):1143-1145.
PMID: 37967035
No abstract available.
3.
Chakravarty N, Poojari V, Shah I
JPGN Rep
. 2023 May;
1(2):e013.
PMID: 37206606
No abstract available.
4.
Mirani S, Poojari V, Shetty N, Shah I
J Clin Exp Hepatol
. 2021 Mar;
11(1):9-13.
PMID: 33679043
Aim: The objective of this study was to determine the outcome of children with tyrosinemia type 1 from India. Methods: A retrospective observational study was conducted on 11 patients diagnosed...
5.
Oberoi A, Poojari V, Shah I
J Pediatr Gastroenterol Nutr
. 2021 Mar;
73(2):e47.
PMID: 33661249
No abstract available.
6.
Poojari V, Shah I, Shetty N, Mirani S, Tolani D
Trop Doct
. 2020 Oct;
51(2):189-192.
PMID: 33106122
We aimed to determine the clinical profile and outcome of Indian children with glycogen storage disorders. Ours was a retrospective study from 2005 to 2018 in 36 children diagnosed on...
7.
8.
Shah I, Poojari V, Meshram H
Indian J Pediatr
. 2020 Feb;
87(10):833-839.
PMID: 32103425
India is one of the high burden countries for tuberculosis (TB) including multi-drug resistant TB (MDR-TB) and extensively-drug resistant (XDR) TB. Drug-resistant (DR) TB has threatened the TB care and...